Delivery Order SPE2DB22D3501-SPE2DB25FWG29
- Not listed
- The Defense Logistics Agency awarded a $11,435.46 delivery order to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 mL vials. This delivery order, issued on September 4, 2025, represents a competitive, non-set-aside award with firm fixed pricing and an ultimate completion date of September 25, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. Yervoy is an immunotherapy medication used in cancer treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a $17,153.19 delivery order to AmerisourceBergen Drug Corp for Yervoy (ipilimumab) 50 mg/10 mL vials on August 21, 2025, with an ultimate completion date of September 12, 2025. This non-competitive delivery order operates under a firm fixed price structure and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Yervoy is a checkpoint inhibitor immunotherapy commonly used in cancer treatment, reflecting the...
- The Defense Logistics Agency awarded a $49,957.75 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Yervoy 200 mg/40 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $102,842.87 to AmerisourceBergen Drug Corp for the supply of Yervoy (ipilimumab) 200 mg/40 mL vials. This competitively awarded, firm fixed-price delivery order is set to be completed by October 20, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $25,022.41 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Yervoy 200 mg/40 mL vials. The contract represents a firm fixed-price delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply...
- The Defense Logistics Agency awarded a $13,499.88 delivery order to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 ml vials, with a completion date of June 24, 2025. This competitive, firm fixed-price delivery order represents a non-set-aside procurement supporting the federal government's pharmaceutical supply requirements. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $11,435.46 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Yervoy 50 mg/10 ml vials. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA....
- The Defense Logistics Agency awarded a $114,789.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of YERVOY 200 mg/40 mL vials. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 28, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $37,864.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of YERVOY (ipilimumab) 200 mg/40 mL vials. The contract, awarded on May 12, 2025, with an ultimate completion date of June 3, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $36,457.87 to AmerisourceBergen Drug Corp for YERVOY (ipilimumab) 200 mg/40 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract was awarded on August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWG29Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,870.92 to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 mL vials on July 2, 2025, with completion targeted for July 24, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order performed at the contractor's facility in Conshohocken, Pennsylvania. Yervoy is a specialized immunotherapy pharmaceutical used in oncology treatment, reflecting the critical role AmerisourceBergen plays in supplying advanced therapeutic medications to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999.00 vehicle running through December 2026. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen supplies a wide range of brand-name and generic drugs, vaccines, and medical supplies to support military and veteran healthcare systems globally. The company's extensive portfolio of federal contract awards demonstrates its capacity to meet diverse medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.9k | 7/2/25 |